InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.
| Revenue (Most Recent Fiscal Year) | $143.44M |
| Net Income (Most Recent Fiscal Year) | $6.63M |
| PE Ratio (Current Year Earnings Estimate) | 27.13 |
| PE Ratio (Trailing 12 Months) | 33.06 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.49 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.75 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.76 |
| Pre-Tax Margin (Trailing 12 Months) | 7.41% |
| Net Margin (Trailing 12 Months) | 4.62% |
| Return on Equity (Trailing 12 Months) | 11.91% |
| Return on Assets (Trailing 12 Months) | 6.55% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.80 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.53 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.34 |
| Inventory Turnover (Trailing 12 Months) | 11.10 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.82 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.10 |
| Earnings per Share (Most Recent Fiscal Year) | $0.31 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.32 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 20.19M |
| Free Float | 18.01M |
| Market Capitalization | $213.65M |
| Average Volume (Last 20 Days) | 0.08M |
| Beta (Past 60 Months) | 1.54 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 10.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 71.13% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |